BKYI — BIO-key International Income Statement
0.000.00%
Last trade - 00:00- $4.99m
- $3.41m
- $5.94m
Annual income statement for BIO-key International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5.11 | 7.02 | 7.75 | 6.93 | 5.94 |
| Cost of Revenue | |||||
| Gross Profit | 3.44 | 4.58 | 1.43 | 5.64 | 4.56 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 10.1 | 17.4 | 16.6 | 10.9 | 12.8 |
| Operating Profit | -4.94 | -10.4 | -8.83 | -4.01 | -6.83 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.07 | -11.9 | -8.66 | -4.32 | -7.14 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5.07 | -11.9 | -8.52 | -4.3 | -7.16 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.07 | -11.9 | -8.52 | -4.3 | -7.16 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.07 | -11.9 | -8.52 | -4.3 | -7.16 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -117 | -230 | -152 | -20.9 | -8.32 |